Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: Current concepts and controversies

por Jayram, Gautam, Szmulewitz, Russell Z., Eggener, Scott E.
Publicado 2010

Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer – A Case Report

por VanderWeele, David J., Paner, Gladell P., Fleming, Gini F., Szmulewitz, Russell Z.
Publicado 2015

Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review

por Mir, Nabiel, Burke, Olivia, Yates, Samuel, Rajasekaran, Tanujaa, Chan, Johan, Szmulewitz, Russell, Kanesvaran, Ravindran
Publicado 2023

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer

por Sweis, Randy F., Zha, Yuanyuan, Pass, Lomax, Heiss, Brian, Chongsuwat, Tara, Luke, Jason J., Gajewski, Thomas F., Szmulewitz, Russell
Publicado 2018

Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prosta...

por Reyes, Edwin E, VanderWeele, David J, Isikbay, Masis, Duggan, Ryan, Campanile, Alexa, Stadler, Walter M, Vander Griend, Donald J, Szmulewitz, Russell Z
Publicado 2014

A randomized phase II study of pazopanib in hormone sensitive prostate cancer: a University of Chicago Phase II Consortium/ Department of Defense Prostate Cancer Clinical Trials Co...

por Ward, James E., Karrison, Theodore, Chatta, Gurkamal, Hussain, Maha, Shevrin, Daniel, Szmulewitz, Russell Z., O’Donnell, Peter H., Stadler, Walter M., Posadas, Edwin M.
Publicado 2011

Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer

por Kregel, Steven, Kiriluk, Kyle J., Rosen, Alex M., Cai, Yi, Reyes, Edwin E., Otto, Kristen B., Tom, Westin, Paner, Gladell P., Szmulewitz, Russell Z., Vander Griend, Donald J.
Publicado 2013

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer

por Kregel, Steven, Chen, James L., Tom, Westin, Krishnan, Venkatesh, Kach, Jacob, Brechka, Hannah, Fessenden, Tim B., Isikbay, Masis, Paner, Gladell P., Szmulewitz, Russell Z., Vander Griend, Donald J.
Publicado 2016

Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Bioche...

por Aggarwal, Rahul, Alumkal, Joshi J., Szmulewitz, Russell Z., Higano, Celestia S., Bryce, Alan H., Lopez-Gitlitz, Angela, McCarthy, Sharon A., Miladinovic, Branko, McQuarrie, Kelly, Thomas, Shibu, Zhang, Ke, Small, Eric J.
Publicado 2022

Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasm...

por Powderly, John, Cote, Gregory, Flaherty, Keith, Szmulewitz, Russell Z, Ribas, Antoni, Weber, Jeffrey, Loo, Deryk, Baughman, Jan, Chen, Francine, Moore, Paul, Bonvini, Ezio, Vasselli, James, Wigginton, Jon, Cohen, Roger, Burris, Howard, Chmielowski, Bartosz
Publicado 2015

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

por Armstrong, Andrew J., Szmulewitz, Russell Z., Petrylak, Daniel P., Holzbeierlein, Jeffrey, Villers, Arnauld, Azad, Arun, Alcaraz, Antonio, Alekseev, Boris, Iguchi, Taro, Shore, Neal D., Rosbrook, Brad, Sugg, Jennifer, Baron, Benoit, Chen, Lucy, Stenzl, Arnulf
Publicado 2019

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)

por Monk, Paul, Liu, Glenn, Stadler, Walter M., Geyer, Susan, Huang, Ying, Wright, John, Villalona-Calero, Miguel, Wade, James, Szmulewitz, Russell, Gupta, Shilpa, Mortazavi, Amir, Dreicer, Robert, Pili, Roberto, Dawson, Nancy, George, Saby, Garcia, Jorge A.
Publicado 2018

A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors

por Michaelson, M. Dror, Gupta, Shilpa, Agarwal, Neeraj, Szmulewitz, Russell, Powles, Thomas, Pili, Roberto, Bruce, Justine Yang, Vaishampayan, Ulka, Larkin, James, Rosbrook, Brad, Wang, Erjian, Murphy, Danielle, Wang, Panpan, Lechuga, Maria Josè, Valota, Olga, Shepard, Dale R.
Publicado 2019

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

por Armstrong, Andrew J., Azad, Arun A., Iguchi, Taro, Szmulewitz, Russell Z., Petrylak, Daniel P., Holzbeierlein, Jeffrey, Villers, Arnauld, Alcaraz, Antonio, Alekseev, Boris, Shore, Neal D., Gomez-Veiga, Francisco, Rosbrook, Brad, Zohren, Fabian, Yamada, Shunsuke, Haas, Gabriel P., Stenzl, Arnulf
Publicado 2022

SOX2 Mediates Metabolic Reprogramming of Prostate Cancer Cells

por de Wet, Larischa, Williams, Anthony, Gillard, Marc, Kregel, Steven, Lamperis, Sophia, Gutgesell, Lisa C., Vellky, Jordan E., Brown, Ryan, Conger, Kelly, Paner, Gladell P., Wang, Heng, Platz, Elizabeth E., De Marzo, Angelo M., Mu, Ping, Coloff, Jonathan L., Szmulewitz, Russell Z., Vander Griend, Donald J.
Publicado 2022

Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer

por Armstrong, Andrew J., Luo, Jun, Nanus, David M., Giannakakou, Paraskevi, Szmulewitz, Russell Z., Danila, Daniel C., Healy, Patrick, Anand, Monika, Berry, William R., Zhang, Tian, Harrison, Michael R., Lu, Changxue, Chen, Yan, Galletti, Giuseppe, Schonhoft, Joseph D., Scher, Howard I., Wenstrup, Richard, Tagawa, Scott T., Antonarakis, Emmanuel S., George, Daniel J., Halabi, Susan
Publicado 2020

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)

por Pachynski, Russell K, Morishima, Chihiro, Szmulewitz, Russell, Harshman, Lauren, Appleman, Leonard, Monk, Paul, Bitting, Rhonda L, Kucuk, Omer, Millard, Frederick, Seigne, John D, Fling, Steven P, Maecker, Holden T, Duault, Caroline, Ramchurren, Nirasha, Hess, Bruce, D’Amico, Leonard, Lacroix, Andreanne, Kaiser, Judith C, Morre, Michel, Grégoire, Anne, Cheever, Martin, Yu, Evan Y, Fong, Lawrence
Publicado 2021

Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics

por Meier, Jason P., Zhang, Hannah J., Freifelder, Richard, Bhuiyan, Mohammed, Selman, Phillip, Mendez, Megan, Kankanamalage, Pavithra H. A., Brossard, Thomas, Pusateri, Antonino, Tsai, Hsiu-Ming, Leoni, Lara, Penano, Sagada, Ghosh, Kaustab, Broder, Brittany A., Markiewicz, Erica, Renne, Amy, Stadler, Walter, Weichselbaum, Ralph, Nolen, Jerry, Kao, Chien-Min, Chitneni, Satish K., Rotsch, David A., Szmulewitz, Russell Z., Chen, Chin-Tu
Publicado 2023

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

por Armstrong, Andrew J., Halabi, Susan, Luo, Jun, Nanus, David M., Giannakakou, Paraskevi, Szmulewitz, Russell Z., Danila, Daniel C., Healy, Patrick, Anand, Monika, Rothwell, Colin J., Rasmussen, Julia, Thornburg, Blair, Berry, William R., Wilder, Rhonda S., Lu, Changxue, Chen, Yan, Silberstein, John L., Kemeny, Gabor, Galletti, Giuseppe, Somarelli, Jason A., Gupta, Santosh, Gregory, Simon G., Scher, Howard I., Dittamore, Ryan, Tagawa, Scott T., Antonarakis, Emmanuel S., George, Daniel J.
Publicado 2019